Human gene
MSTN myostatin
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 683 | Muscular hypertrophy (double muscling) | domestic cattle | MSTN | one to one | Drug |
54.1
|
| 2161 | Leg weakness, MSTN-related | pig | MSTN | one to one | Drug |
49.1
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| myostatin-related muscle hypertrophy | MONDO:0013598 | 0.50 | 57 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Apitegromab | inhibitor | Phase 3 |
| Domagrozumab | inhibitor | Phase 2 |
| Landogrozumab | inhibitor | Phase 2 |
| Ramatercept | inhibitor | Phase 2 |
| Trevogrumab | inhibitor | Phase 2 |
| Stamulumab | inhibitor | Phase 1/2 |
| Pf-03446879 | inhibitor | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.